AVEO
Asset Logo

Avecho Biotechnology Limited

🇦🇺 ASX

Compare
Add to watchlist
👑 Overview

📈 Performance

💵 Cost

🤓 Advanced

👨‍👩‍👧‍👦 Community

📈

-21.36%
Annual Growth

4 years average annual growth

💵

$ 500
Minimum Order

Due to regulatory requirements

🌏

0
Pearlers Invested

Since January 2020

👑 Overview

Key information
🔎 Fund Overview

Avecho Biotechnology Limited - Option Expiring 31-Dec-2023

📈 Performance

Price History

-80.00%

1M

All Time

Graph

Table

Unsure how much or often to invest?
🗓️ Investing frequency calculator

Determine the investment frequency needed to reach your goals

Try it out →
💵 Investing amount calculator

Determine the recurring investment needed to reach your goals

Try it out →
⏱️ Investing duration calculator

Determine how long you will need to invest to reach your goals

Try it out →

💵 Costs

💵

6.50 AUD*
Purchase Fee

*$5.50 with Pearler Prepay

💼

N/A
Management Fee

Included in unit price, not charged by Pearler

💸

Want to know the long term costs?
Calculate the historic long term costs to hold your investments
💸 Net fee calculator

🤓 Advanced information

Technical Info

💰 Price*

$0.00

*Price may be up to 24 hours old

👩‍👩‍👦 Community Insights

How our community is investing

🌏 Pearlers invested in AVEO

0

📊 Total Capital Earnings

N/A

🔃 Average investment frequency

N/A

💵 Average investment amount

N/A

Last time a customer invested in AVEO

N/A
AVEO investor breakdown
💵 Income of investors

More than 200k

150k - 200k

100k - 150k

50k - 100k

Less than 50k

👶 Age of investors

18 - 25

26 - 34

35 - 90

🙋 Legal gender of investors

Female

Male

Pearlers who invest in AVEO also invest in...

Australian Pacific Coal Limited

AQC

Australian Pacific Coal Ltd. engages in the exploration, development, and production activities at the mining tenements situated in Queensland and New South Wales. The company is headquartered in Brisbane, Queensland. The Company’s principal activities include exploration and development activities at mining tenements situated in New South Wales, Australia. The Company’s Dartbrook Project is located in the coal region of the Hunter Valley, New South Wales, approximately four-kilometer (km) west of Aberdeen and 10 km north-west of Muswellbrook. The firm produces thermal coal product comparing with thermal coal provided by adjacent operations and the Newcastle export benchmark. In Queensland, the Company holds interests in the Matuan Downs Bentonite Project and a Joint Venture interest on tenements with Blackwood Resources. Its subsidiaries include AQC Investments 1 Pty Ltd, AQC Investments 2 Pty Ltd, Area Coal Pty Ltd, AQC Services Pty Ltd, AQC Dartbrook Pty Ltd, AQC Dartbrook Management Pty Ltd, and Ipoh Pacific Resources Pty Ltd.

📊 Share price

$0.15 AUD
Find Out More

AVITA Medical, Inc., through its subsidiaries, engages in the development and commercialization of a technology platform that enables point-of-care autologous skin restoration for multiple unmet needs. The company is headquartered in Valencia California, California. The company went IPO on 2012-03-18. The firm is engaged in the development and commercialization of devices and autologous cellular therapies for skin restoration. The Company’s RECELL System is a single use (disposable), stand-alone, battery operated, autologous cell harvesting device containing enzymatic and buffer solutions, sterile surgical instruments, and actuators to achieve the disaggregation and delivery of skin cells. The platform technology of the RECELL System allows for the preparation and delivery of Spray-On Skin Cells, an autologous cellular suspension comprised of the patient’s own skin cells necessary to regenerate natural healthy epidermis. These Spray-On Skin Cells are prepared at the point of care, providing a new way to treat thermal burns, other wounds, skin injuries or defects of the skin. The RECELL System is designed to be used at the point of care alone or in combination with autografts, depending on the depth of the burn injury.

📊 Share price

$3.39 AUD

Carnegie Clean Energy Ltd. engages in the development and ownership of the patented CETO wave energy technology. The firm is focused on the development and commercialization of its CETO and MoorPower wave energy technologies and complimentary products, including the Wave Predictor and Mooring Tensioner. CETO is a submerged, point absorber type wave energy technology. CETO is an advanced wave energy system suitable for a range of remote and utility scale markets globally. MoorPower is an integrated wave energy system for offshore demand applications such as offshore aquaculture. Wave Predictor is a system capable of precisely predicting upcoming waves using a machine learning algorithm that enables intelligent control for wave energy converters and supports optimized performance and costs. Mooring Tensioner is a product that provides the passive tension required for rotary electric power take-off systems. Its projects include Garden Island Microgrid, Microsoft AI for Earth project, CETO Next Generation and others.

📊 Share price

$0.00 AUD

Commonwealth Bank of Australia engages in the provision of banking and financial services. The company is headquartered in Sydney, New South Wales and currently employs 48,860 full-time employees. The firm provides retail and commercial banking services predominantly in Australia and in New Zealand through its subsidiary, ASB. The company serves approximately 16 million customers. The firm's segments include Retail Banking Services, Business Banking, Institutional Banking and Markets and New Zealand. Retail Banking services provides banking and general insurance products and services to personal and private bank customers. Business Banking serves the banking needs of business, corporate and agribusiness customers across the full range of financial services solutions, as well as providing equities trading and margin lending services through the CommSec business. Institutional Banking and Markets serves the commercial and wholesale banking needs of large corporate, institutional and government clients. New Zealand includes the banking and funds management businesses operating under the ASB brand.

📊 Share price

$99.50 AUD

NULL BANKS

AustChina Holdings Ltd. engages in developing and investing in early stage coal exploration projects. The company is headquartered in Brisbane, Queensland. The company went IPO on 2003-03-17. The Company’s exposure in the resources and energy sectors include its Blackall Coal Project, investment interests in copper exploration and a holding in Energy from Organic Waste developer Utilitas Group Pty Ltd. The Company’s Blackall Coal Project is located approximately 130 kilometers (km) south-west of the Alpha area coal projects. The firm holds two exploration permits for coal, EPC1719 and EPC1993, located near Blackall in Central Queensland. The EPC1719 and EPC1993 comprise a single project-based administration area and are located in the north-western corner of the Blackall Coal Project near the township of Blackall and centered approximately 20 km south-east of the town. The firm holds 25.12% of Utilitas Group Pty Ltd, that is engaged in the Biogas renewable energy sector.

📊 Share price

$0.01 AUD

Want more shares? Try these...

📊 Share price

$0.00 AUD

Australian Vintage Ltd. engages in wine making, wine marketing, and vineyard management. The company is headquartered in Adelaide, South Australia and currently employs 450 full-time employees. The principal activities of the Company are wine making, wine marketing and vineyard management company. The firm operates in three segments: Australia / New Zealand, UK, Europe & Americas and Asia. The Australia / New Zealand segment is engaged in the manufacturing, sales and marketing of wine in Australia, New Zealand and the Pacific through wholesale and retail channels. The UK, Europe & Americas segment is engaged in the packaging, sales and marketing of wine in the United Kingdom, Europe & the Americas through wholesale, distributor and retail channels. The Asia segment is engaged in the sales and marketing of wine in Asia through wholesale channels. The Company’s brands include McGuigan Wines, Tempus Two, Nepenthe, and Barossa Valley Wine Company. The McGuigan Wines volume includes #1 Black Label Red, #3 Black Label Cabernet Merlot and #6 Black Label Merlot.

📊 Share price

$0.48 AUD

AVADA Group Ltd. engages in the provision of traffic management and ancillary service. The company is headquartered in Brisbane, Queensland. The company went IPO on 2021-12-17. The firm operates through three segments: Queensland Traffic Management, New South Wales Traffic Management, and Victoria Traffic Management. Queensland Traffic Management contains entities which operate in the Queensland geography. New South Wales Traffic Management contains entities which operate in the New South Wales geography. Victoria Traffic Management contains entities which operate in the Victorian geography. The firm provides services to government clients and major contractors in the civil infrastructure and maintenance sector. Its businesses include Verifact Traffic, A2O Traffic Solutions, D&D Traffic Management, Platinum Traffic Services, Traffic Marshal, Construct Traffic, TRAFFIC MANAGEMENT PEOPLE (TMP) and Linemark Traffic Control.

📊 Share price

$0.70 AUD

Avecho Biotechnology Ltd. engages in the development, production, sale, and licensing of products incorporating its patented platform technology, Targeted Penetration Matrix (TPM), for the pharmaceutical, skin care and animal health and nutrition industries. The company is headquartered in Melbourne, Victoria. The firm develops and commercializes human and animal health products using its drug delivery system Tocopherol Phosphate Mixture (TPM). The firm's products pipeline includes Weaner Pig Starter TPM premix, Poultry TPM, Dairy TPM, Daptomycin, Propofol and Veterinary Applications. The firm's segments include Production and Human Health. The Production segment manufactures and sells TPM and Vital ET for the use in drug delivery and cosmetic formulations. The Company’s Human Health segment covers delivery of pharmaceutical products through gels, injectables and patches. This segment focuses on the development of patches, including TPM/Oxymorphone, TPM/enhanced, and TPM/Oxycodone. The firm is also developing TPM to enhance feed efficiency and health of livestock. Its TPM products are commercialized under license Voveran TPM Gel, Instanac TPM Gel, Vital ET, and Ashland TPM.

📊 Share price

$0.01 AUD
Compare
Add to watchlist